Regulatory communication strength 3D Communications specializes in transforming complex scientific information for regulatory, payer, and policy audiences across US and EU. This positions them to upsell advisory and content development services for regulatory submissions, market access dossiers, and stakeholder engagement campaigns.

Biotech pharma focus With over two decades serving pharmaceutical, biotech, and medical device clients, there is a ready-made cross-sell path into sponsors seeking expert messaging, regulatory strategy, and stakeholder outreach to support high-stakes interactions and approvals.

3D ACT leverage The proprietary 3D ACT process and advanced technology stack indicate scalable, repeatable messaging and presentation capabilities, suggesting opportunities for standardized service packages, training programs, and technology-enabled content production for multiple clients.

Mid-market potential Employee count and revenue place 3D between small firms and large multinational agencies, presenting a sweet spot for growth through expanded account management, deep-dive capabilities in market access, and tiered service bundles attractive to mid-size biopharma organizations.

Digital and analytics readiness Current tech stack features SEO, analytics, and web optimization tools indicating a foundation for data-driven marketing, demand generation, and measurable ROI proposals to clients seeking improved regulatory communications and public-facing presentations.